Linked Life Data

9917523

Source:http://linkedlifedata.com/resource/pubmed/id/9917523

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-10-16
pubmed:abstractText
Proliferative activity of 17 craniopharyngiomas were determined using an immunohistochemical method with monoclonal antibody MIB-1. A considerable variation of the MIB-1 labeling indices was found between the different tumors with a minimum of 0.4% and a maximum of 32.5% (median, 10.84%). The mean MIB-1 labeling index (LI) for 4 craniopharyngiomas that showed no evidence of recurrence (n=4) was 3.4 +/- 2.3%. This was significantly lower than that for craniopharyngiomas that showed recurrence and regrowth (13.2 +/- 7.7%) (n=13), based on the initial resected tumors. Statistical analysis reveal that craniopharyngiomas with an MIB-1 LI of 7% or more have a significantly high tendency for recurrence and regrowth during clinical course. Our data suggest that a MIB-1 LI greater than 7% may be a useful predictor of regrowth/recurrence of craniopharyngiomas and may be useful for planning of adjuvant therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1107-3756
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
157-61
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma.
pubmed:affiliation
Department of Neurosurgery, Kumamoto University School of Medicine, Honjo, Kumamoto 860-8556, Japan.
pubmed:publicationType
Journal Article